Artemether and lumefantrine and Genotropin Miniquick
Determining the interaction of Artemether and lumefantrine and Genotropin Miniquick and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Somatropin may reduce the blood levels of artemether, which may make the medication less effective in treating malaria in some cases. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. Contact your doctor if your symptoms worsen or your condition changes during treatment with these medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: Coadministration with inducers of CYP450 3A4 may decrease the plasma concentrations of artemether and lumefantrine, both of which are primarily metabolized by the isoenzyme. Loss of antimalarial efficacy may occur. In six HIV-1 and tuberculosis coinfected adults without malaria, administration of artemether-lumefantrine (six-dose regimen over 3 days) with the potent CYP450 3A4 inducer rifampin (600 mg orally daily) decreased the systemic exposure (AUC) to artemether, dihydroartemisinin (the active metabolite of artemether) and lumefantrine by 89%, 85% and 68%, respectively. No data are available for use with other, less potent inducers.
MANAGEMENT: Concomitant use of artemether-lumefantrine with CYP450 3A4 inducers should generally be avoided. Otherwise, caution is advised, and patients should be closely monitored for potentially diminished clinical response to artemether-lumefantrine therapy.
- "Product Information. Coartem (artemether-lumefantrine)." Novartis Pharmaceuticals, East Hanover, NJ.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
Generic Name: artemether / lumefantrine
Brand name: Coartem
Synonyms: Artemether and Lumefantrine
Generic Name: somatropin
Brand name: Genotropin, Humatrope, Norditropin FlexPro Pen, Nutropin AQ NuSpin 10, Nutropin AQ Pen 10 Cartridge, Omnitrope, Saizen, Serostim, Zomacton, Zorbtive, Genotropin Miniquick, Norditropin Nordiflex Pen, Tev-Tropin, Nutropin, Norditropin, Nutropin AQ, Nutropin Depot, Norditropin Cartridge, Saizen Click-Easy, Omnitrope Pen 5 Cartridge, HumatroPen, Omnitrope Pen 10 Cartridge, Nutropin AQ Pen 20 Cartridge, Nutropin AQ NuSpin 5, Nutropin AQ NuSpin 20, Saizen Kit
Synonyms: Genotropin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Artemether and lumefantrine-Genpril
- Artemether and lumefantrine-Gentamicin
- Artemether and lumefantrine-Gentamicin (Systemic)
- Artemether and lumefantrine-Gentamicin and prednisolone ophthalmic
- Artemether and lumefantrine-Gentamicin Cream
- Artemether and lumefantrine-Gentamicin Injection
- Genotropin Miniquick-Arthricare Cream
- Genotropin Miniquick-Arthricare For Women Topical
- Genotropin Miniquick-Arthriten
- Genotropin Miniquick-Arthritis Pain
- Genotropin Miniquick-Arthritis Pain Relief
- Genotropin Miniquick-Arthrotec